-
Subscribe
for Free
-
-
Our
Cities▾
-
Tech
Channels ▾
-
Meet the
Xconomists ▾
-
Professor, J. David Gladstone Institute of Cardiovascular Disease
-
Chairman, CEO, Acucela
-
Senior Partner, Bessemer Venture Partners
-
CEO and Co-Founder, Sage Bionetworks
-
Meet All the Xconomists ›
-
Founder, Gilt Groupe
-
Co-Founder and Managing Member, Psilos Group
-
Chair, Dept. of Cellular and Molecular Pharmacology, UCSF
-
Professor of Computer Science, UC San Diego
-
Our
Events ▾
-
|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
OncoGenex Snags $50M for Prostate Cancer Drug Plan
|
Luke Timmerman |
03/16/12 |
Seattle
|
|
OncoGenex Doubles Down on Prostate Cancer, As Competition Heats Up
|
Luke Timmerman |
03/08/12 |
Seattle
|
|
OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation
|
Luke Timmerman |
01/27/12 |
Seattle
|
|
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups
|
Luke Timmerman |
12/22/11 |
Seattle
|
|
Dendreon’s Blow-Up, Epigenomics Leaves Town, Presage Adds $1.5M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/11/11 |
Seattle
|
|
OncoGenex Drops on Trial Delay
|
Luke Timmerman |
08/05/11 |
Seattle
|
|
ZymoGenetics CEO Exits Stage, Resolve’s Recession-Era Biotech Plan, Ikaria Pulls IPO, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/11/10 |
Seattle
|
|
OncoGenex Hires Burris
|
Luke Timmerman |
11/08/10 |
Seattle
|
|
Intellectual Ventures’ Med-Tech Foray, PATH Takes Ultra Rice to Africa, Mirador Gets FDA OK, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/21/10 |
Seattle
|
|
OncoGenex Raises $50M
|
Luke Timmerman |
10/19/10 |
Seattle
|
|
Mersana Strikes Deal With Teva Worth up to $334M for Long-Lasting Cancer Drug
|
Luke Timmerman |
04/13/10 |
Boston
|
|
FDA Panel Slams Cell Therapeutics, Oncothyreon Slumps, Biotech’s Healthcare Victory, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
03/25/10 |
Seattle
|
|
OncoGenex Adds New Chairman
|
Luke Timmerman |
03/24/10 |
Seattle
|
|
Dendreon’s False Rumor, Cell Therapeutics’ New FDA Day, Microsoft’s Health-IT Plan, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
03/04/10 |
Seattle
|
|
OncoGenex CFO Exits
|
Luke Timmerman |
02/25/10 |
Seattle
|
|
A Brief Year-End Review of Seattle Biotech
|
Stewart Lyman |
12/31/09 |
Seattle
|
|
Cell Therapeutics Dangles Exec Bonuses, Oncothyreon’s Turnaround Year, VLST Layoffs, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
12/24/09 |
Seattle
|
|
Zulily Gets Funded, Ontela Merges with Photobucket, OncoGenex Secures $60M from Teva, & More Seattle-Area Deals News
|
Gregory T. Huang |
12/22/09 |
Seattle
|
|
Isis Nabs $10M from OncoGenex Deal
|
Luke Timmerman |
12/21/09 |
San Diego
|
|
OncoGenex Grabs $60M Upfront From Teva for Rights to Cancer Drug, Shares Drop Anyway
|
Luke Timmerman |
12/21/09 |
Seattle
|
|
From Russia With Love (for Biotech), Stewart Parker Gets “Antsy” to Return
|
Luke Timmerman |
12/14/09 |
Seattle
|
|
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009
|
Luke Timmerman |
09/22/09 |
Seattle
|
|
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/06/09 |
Seattle
|
|
OncoGenex, Toiling in Dendreon’s Shadow, Scopes Out Partners For Prostate Cancer Drug
|
Luke Timmerman |
08/05/09 |
Seattle
|
|
ZymoGenetics Picks Up Mojo, Dendreon Looks Southeast, Cell Therapeutics Raises Dough & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/23/09 |
Seattle
|
|
OncoGenex Raises $9.5M
|
Luke Timmerman |
07/20/09 |
Seattle
|
|
OncoGenex Pharmaceuticals Lands $9,500,000 New Funding
|
VentureDeal |
07/20/09 |
Seattle
|
|
Stem Cell Entrepreneur Quinn Dies, Dendreon Tames Shorts, PhysioSonics Monitors Brain Blood, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/02/09 |
Seattle
|
|
CTI, OncoGenex Join Russell Indexes
|
Luke Timmerman |
06/30/09 |
Seattle
|
|
Dendreon Resists Urge to Sell Out, NanoString Nabs $30M, VC Firm Cashes Out on OncoGenex, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
06/11/09 |
Seattle
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.